| Source Date | Board Meeting Date | Details |
|
30-Oct-2024
|
05-Nov-2024
|
Quarterly Results
|
|
24-Jul-2024
|
01-Aug-2024
|
Quarterly Results
|
|
16-May-2024
|
22-May-2024
|
Final Dividend & Audited Results
|
|
20-Jan-2024
|
31-Jan-2024
|
Quarterly Results
|
|
27-Oct-2023
|
06-Nov-2023
|
Quarterly Results
|
|
28-Jul-2023
|
07-Aug-2023
|
Quarterly Results
|
|
10-May-2023
|
16-May-2023
|
Final Dividend & Audited Results
|
|
25-Jan-2023
|
02-Feb-2023
|
Quarterly Results & Inter alia, to consider and approve Proposal for Issue of Non-Convertible Debentures
|
|
21-Oct-2022
|
01-Nov-2022
|
Quarterly Results
|
|
27-Jul-2022
|
10-Aug-2022
|
Quarterly Results
|
|
18-May-2022
|
25-May-2022
|
Audited Results
|
|
02-Feb-2022
|
12-Feb-2022
|
Quarterly Results
|
|
01-Nov-2021
|
12-Nov-2021
|
Quarterly Results
|
|
02-Aug-2021
|
10-Aug-2021
|
Quarterly Results
|
|
20-May-2021
|
28-May-2021
|
Audited Results
|
|
27-Jan-2021
|
06-Feb-2021
|
Quarterly Results
|
|
30-Oct-2020
|
11-Nov-2020
|
Quarterly Results
|
|
27-Aug-2020
|
01-Sep-2020
|
Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2020 ,inter alia, to consider and approve 1.Consider the management accounts (standalone as well as consolidated) for the quarter ended June 30, 2020 of the Company. 2.Consider and recommend to the shareholders, the Employee Stock Option Policy of the Company 3.Consider raising funds by issue of equity shares and / or any other equity linked securities, through permissible modes, including but not limited to, qualified institutions placement, preferential allotment or such other permissible mode or combinations thereof, in one or more tranches, as may be decided, subject to approval of the shareholders and regulatory and other approvals, each as may be required; 4.Enabling approval for private placement of Non Convertible Debentures, in one or more tranches; 5.Fixing the date of the forthcoming Annual General Meeting of the Company and approval of notice thereof including the matters referred under clause (2) to (4) above
|